معرفی
Dr. Preeti Pandey serves as a Research Officer and Honorary Research Fellow at The University of Queensland's School of Pharmacy and Pharmaceutical Sciences, specializing in advanced drug delivery systems for mucosal administration routes. Her work bridges pharmaceutical science and clinical applications, with a focus on developing localized therapies for conditions ranging from sinusitis to sexually transmitted infections.
Her research expertise spans sol-gel formulations, nanoparticle drug carriers, and transmucosal delivery systems, particularly for intranasal and intravaginal applications. Key projects include clozapine-loaded thermosensitive gels for nose-to-brain delivery, doxycycline-infused sol-gels for localized gonorrhoea management, and tacrolimus-embedded hydrogels for dermatological conditions. Her methodology integrates material science with physiological considerations to optimize drug release kinetics and tissue targeting.
Analysis of her 15 most recent publications reveals a consistent trajectory in mucosal drug delivery innovation, with increasing focus on antimicrobial applications (2024-2025) and nanocarrier integration (2021-2023). The work demonstrates strong translational potential, with multiple patent filings for cannabinoid and sol-gel compositions indicating commercialization efforts.
Her doctoral research (2018) established foundational work on corticosteroid nasal gels for post-operative sinusitis, which has evolved into broader applications for antipsychotics and antimicrobials. Collaborative networks include significant partnerships with Harendra S. Parekh across 15+ publications, suggesting a core research team structure within the School of Pharmacy.
